Tempus AI

Tempus AI Inventory

The Inventory of Tempus AI (TEM) as of Nov 4, 2026 is 51.72 M USD. In the previous year, Inventory was 38.39 M USD — a change of 34.75% (higher).

Inventory

51.72 MUSD

YoY

34.75%

Last updated:

Inventory of Tempus AI is 2025 51.72 M USD. Inventory of Tempus AI was 2024 38.39 M USD. It decreases by 34.75% higher compared to the previous year.

The Tempus AI Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2019
8.28 M USD
Jan 1, 2020
37.56 M USD
Jan 1, 2021
22.91 M USD
Jan 1, 2022
22.28 M USD
Jan 1, 2023
28.85 M USD
Jan 1, 2024
38.39 M USD
Jan 1, 2025
51.72 M USD
The Tempus AI Inventory history
YEARInventoryYoY
51.72 MUSD+34.75%
38.39 MUSD+33.08%
28.85 MUSD+29.45%
22.28 MUSD-2.73%
22.91 MUSD-39.00%
37.56 MUSD+353.64%
8.28 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Tempus AI Stock analysis

What does Tempus AI do? Tempus AI Inc provides next generation diagnostics through genomics, data, and AI applications. Its genomics product line includes next generation sequencing, diagnostics, PCR, profiling, molecular genotyping, and pathology testing. The AI applications focus on algorithmic diagnostics, software as a medical device, and clinical decision support tools. The primary AI product Next uses machine learning to identify care gaps for oncology and cardiology patients. The company serves healthcare providers and life sciences organizations seeking personalized medicine solutions. Tempus AI Inc's revenue comes from its genomics and AI product lines. The genomics services are delivered through its laboratories, offering sequencing, diagnostics, and molecular testing. The AI applications, particularly Next, are sold as software solutions to healthcare institutions. The target customers are healthcare providers and life sciences companies that require advanced diagnostic tools for personalized treatment plans. The company operates in the Life Sciences Tools & Services industry, focusing on oncology and cardiology segments. The company's genomics product line generates revenue through laboratory services for molecular pathology testing. AI applications like Next are sold as medical device software, targeting healthcare institutions for clinical decision support. The primary segments served are oncology and cardiology, where personalized medicine is critical. The company's products are designed to integrate with existing healthcare data systems to improve patient care outcomes. Tempus AI is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Tempus AI stock

Inventory of Tempus AI is 51.72 M USD in 2025.

Inventory of Tempus AI changed from 38.39 M USD to 51.72 M USD, representing a 34.75% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Inventory Tempus AI since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's Tempus AI historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Tempus AI

All Key Metrics — Tempus AI